Financial Shenanigans

The Forensic Verdict

DPE earns a Forensic Risk Score of 52 (Elevated). The accounts are audited, unqualified, and there is no restatement, regulator action, or auditor change on record — but the gap between the story management tells with non-IFRS "Underlying" earnings and the audited statutory result has widened past the point where it can be ignored. In FY25, an audited statutory loss of A$3.7M is reframed as A$116.9M of "underlying" profit by adding back A$162.3M of pre-tax "significant items" that the company explicitly says are "not subject to audit or review", and management's own "ongoing" free cash flow figure of A$105.5M sits A$58M above the A$47.4M the business actually produced. The cleanest offsetting evidence: an unqualified audit opinion, low stock-based comp, no receivable factoring or supplier-finance flag in the disclosed notes, and a CFO-to-net-income series distorted by impairments rather than aggressive accruals. The one data point that would most change the grade: whether FY26 produces another year of "non-recurring" charges — a fifth straight year would convert the yellow flag on recurring add-backs into a red one.

The CFO/NI of 5.0× and FCF/NI of 3.6× look reassuring on paper but reflect impairment-suppressed net income, not unusually strong cash generation. The FY25 accruals are net-negative (CFO above net income) because A$162M of write-downs are non-cash — a mechanical, not earned, outperformance. The cash-flow quality test that matters here is what management calls free cash flow, not what the statements show, and that test fails.

Shenanigans Scorecard

The single most material finding is the D1/B3 pairing: the company runs its public narrative on an un-audited "underlying" measure whose only purpose is to subtract restructuring, impairment, and store-closure costs that have now appeared in five consecutive fiscal years. That is the definition of a "non-recurring" charge that recurs.

Breeding Ground

The governance setup amplifies, rather than dampens, the accounting risk.

Three points compound. First, the LTI structure pays out on "underlying" EPS calculated on "constant currency" — both adjustments push the incentive away from the audited statutory number and toward the management-defined view. Second, Cowin's 26% stake and Executive Chair role mean the controlling shareholder is now the operating principal, and the company felt the need to set up an Independent Board Committee explicitly to police related-party transactions. Third, the rapid CEO turnover (Meij in November 2024, van Dyck out by July 2025) means the FY25 books were closed during the leadership transition where big-bath behaviour is statistically most common.

The audit committee is, on paper, the strongest part of the governance map: it is chaired by a former PwC senior audit partner with no disclosed independence issue.

Earnings Quality

Earnings quality is the most worked-over area on this name. The headline issue is not that the audited numbers are wrong — they are signed off without qualification — but that the audited numbers are not the numbers management or sell-side are using.

The "underlying" line has averaged A$149.7M and varied 38% peak-to-trough. The statutory line averaged A$98.2M and varied 197% — going from A$193M of profit in FY21 to a A$3.7M loss in FY25. The full delta between them is captured by "significant items", which the directors' report explicitly states is a non-IFRS measure not subject to audit or review.

Capex compression to 0.26× D&A is the second-order earnings-quality signal. Some of it is real: closing 312 stores reduces required maintenance capex. But intangibles purchases stayed flat at ~A$47M per year through the same period, suggesting the company is steering investment into software/digital and away from physical assets that get depreciated quickly. That keeps current-period depreciation falling faster than capex falls — flattering EBIT margin in a way that is hard to call "fraudulent" but easy to call "stretching."

DSO drifted from 26.4 days in FY21 to 33.9 days in FY25. Not alarming in absolute terms (receivables are A$214M against A$2.3B revenue), but the FY25 14.6% receivable growth against a 3.1% revenue decline does not pass the simple "receivables shouldn't outrun revenue" test.

Cash Flow Quality

Reported operating cash flow looks resilient on a 5-year average; reported "free cash flow" looks even better. Both lean on items that should not extrapolate.

The acquisition-adjusted line tells the story management's headline FCF omits. Across FY22 and FY23, when the Malaysia/Singapore/Cambodia consolidation and other acquisitive moves cost A$492M of cash, FCF after acquisitions was negative A$270M cumulative. Only the past two years (FY24/FY25) show post-M&A self-funding.

The other CFO booster to scrutinise is "other amortization" added back to operating cash flow: A$33.6M in FY24, A$40.3M in FY25 — both well above the historical A$1-2M run-rate. That implies the company is capitalising more, depreciating it on a different schedule, and adding the non-cash piece back to CFO. The economic question is whether the underlying outflow is operating in nature (employee retention costs, technology run costs, customer-acquisition spend) — note 14 of the financial statements should clarify.

Management's own FCF definition is more flattering than the statements: on the FY25 call, the CFO described "free cash flow of A$47.4M" and then immediately presented "A$105.5M on an ongoing basis" excluding A$58.1M of cash outflows on the same significant items already excluded from "underlying" earnings. There are now two adjusted layers (NPAT and FCF) both stripping out the same recurring "non-recurring" cost line. That is metric-on-metric stacking.

Metric Hygiene

This is where the forensic risk concentrates.

The metric-hygiene picture is consistent across the income statement, cash flow statement, and the LTI vesting formula: the audited number is published in full, but every commentary, target, and incentive defaults to the non-audited variant. The pattern is most acute in FY23 (97.9 of after-tax adjustments) and FY25 (120.6) — the two years bracketing the CEO transition.

A 2-4% gap is normal accounting hygiene. The FY23 spike (70%) and the FY25 spike (103%) suggest the "significant items" bucket is acting as a strategic earnings switch, not a one-off cleanup.

What to Underwrite Next

The accounting risk on DPE is not a thesis breaker. It is a valuation modifier: when the company points at A$116.9M of profit and A$105.5M of "ongoing" FCF, the audited business produced a A$3.7M loss and A$47.4M of cash. A reasonable underwriting stance treats the underlying number as the ceiling, not the floor, and tests every forward-looking model against statutory performance.

Five things to monitor:

1. FY26 significant items. If a sixth consecutive year of "non-recurring" charges appears, the non-IFRS bridge stops being an explanation and becomes the entire accounting framework. Threshold for downgrade: any further A$20M+ pre-tax line below "underlying EBIT".

2. Related-party purchase scope. ComGroup Supplies and Franklin Foods are A$24.7M of related-party purchases with A$3.7M outstanding at year-end. The Independent Board Committee was created specifically to police this. Watch for the next AR's RPT note: any increase in scope, an extension to new categories (logistics, real estate, technology), or any expansion of outstanding balances, would be a yellow-to-red flag.

3. Capex / D&A normalisation. Capex at 26% of D&A is unsustainable on a steady-state footprint. Either it bounces back toward 70-90% (confirming FY25 was a closure-year low) or it stays compressed (suggesting margin support that is not durable). FY26 capex landing under 40% of D&A is the second monitor.

4. Net leverage trajectory. Management's 2.57x ratio (underlying EBITDA basis) exceeds the 2.0x target and would deteriorate further on the statutory measure. Watch interim covenant headroom disclosures and any new disclosure of supplier-finance, factoring, or off-balance-sheet structures that could mask leverage.

5. CEO appointment. The new CEO inherits A$162M of FY25 "kitchen-sink" charges. The forensic test is whether they take another big charge in FY26 (more big-bath) or whether the underlying number actually normalises. The former is a downgrade signal; the latter is an upgrade signal and the only realistic path to a "Watch" grade.

Things that would upgrade the grade: a clean FY26 statutory result with no significant items, an explicit Audit and Risk Committee statement that underlying-profit reconciliations have been reviewed (not just the statutory statements), and reduction in related-party purchase volumes following IBC oversight.

Things that would downgrade: any disclosure of supplier finance / receivables sales, an auditor change without explanation, a sixth year of recurring "non-recurring" charges, an expansion of related-party scope, or any new working-capital line that flatters CFO without a clear operating driver.

Bottom line for the investor. This is not a fraud story and not a Watch story either. It is an Elevated-risk story where the gap between the audited result and the headline result is wide enough to require a valuation haircut — apply a 15-25% margin of safety against the company's "underlying" earnings base — and to limit position size until the FY26 cycle clarifies whether the "non-recurring" cost base has actually ended.